Literature DB >> 8408001

Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia.

G L Wang1, G L Semenza.   

Abstract

Hypoxia-inducible factor 1 (HIF-1) is a DNA binding activity detected in nuclear extracts from Hep3B cells cultured in 1% O2 but not in extracts from cells cultured in 20% O2. HIF-1 binds to a sequence within the human erythropoietin gene enhancer that is required for hypoxic activation of transcription. Induction of HIF-1 is inhibited by cycloheximide, which also inhibits induction of erythropoietin RNA. We now demonstrate that induction of both HIF-1 and erythropoietin RNA is inhibited by the protein kinase inhibitor 2-aminopurine. HIF-1 binding to DNA was eliminated by phosphatase treatment of nuclear extracts. Actinomycin D also inhibited HIF-1 induction, suggesting that de novo transcription is required. The kinetics of HIF-1 induction by hypoxia paralleled the kinetics of erythropoietin gene transcriptional induction. HIF-1 DNA binding activity decayed rapidly when hypoxic cells were exposed to increased oxygen tension. In vitro, the kinetics of HIF-1 association with, and dissociation from, its binding site were extremely rapid, with a t1/2 for both processes of < 1 min. These findings are consistent with the proposed function of HIF-1 as a physiologic regulator of gene expression that responds to changes in cellular oxygen tension. Methylation interference analysis indicated that HIF-1 makes specific contacts with DNA in the major groove.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408001

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  220 in total

Review 1.  Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors.

Authors:  H Malonne; I Langer; R Kiss; G Atassi
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

2.  RNA stability in human liver: comparison of different processing times, temperatures and methods.

Authors:  Serene M L Lee; Celine Schelcher; Sevdije Gashi; Stefanie Schreiber; Reinhard M K Thasler; Karl-Walter Jauch; Wolfgang E Thasler
Journal:  Mol Biotechnol       Date:  2013-01       Impact factor: 2.695

3.  Chimeric p53 as an alternative therapy for hypoxic tumors.

Authors:  Jun-Ho Lee; Hua Lu
Journal:  Cancer Biol Ther       Date:  2011-01-01       Impact factor: 4.742

4.  Characterization of the alpha1B-adrenergic receptor gene promoter region and hypoxia regulatory elements in vascular smooth muscle.

Authors:  A D Eckhart; N Yang; X Xin; J E Faber
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

5.  Hypoxia Restrains Lipid Utilization via Protein Kinase A and Adipose Triglyceride Lipase Downregulation through Hypoxia-Inducible Factor.

Authors:  Ji Seul Han; Jung Hyun Lee; Jinuk Kong; Yul Ji; Jiwon Kim; Sung Sik Choe; Jae Bum Kim
Journal:  Mol Cell Biol       Date:  2019-01-03       Impact factor: 4.272

6.  PGC-1alpha is coupled to HIF-1alpha-dependent gene expression by increasing mitochondrial oxygen consumption in skeletal muscle cells.

Authors:  Kathleen A O'Hagan; Sinead Cocchiglia; Alexander V Zhdanov; Murtaza M Tambuwala; Murtaza M Tambawala; Eoin P Cummins; Mona Monfared; Terence A Agbor; John F Garvey; Dmitri B Papkovsky; Cormac T Taylor; Bernard B Allan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

7.  Regulation of renal epithelial tight junctions by the von Hippel-Lindau tumor suppressor gene involves occludin and claudin 1 and is independent of E-cadherin.

Authors:  Sarah K Harten; Deepa Shukla; Ravi Barod; Alexander Hergovich; Maria S Balda; Karl Matter; Miguel A Esteban; Patrick H Maxwell
Journal:  Mol Biol Cell       Date:  2008-12-10       Impact factor: 4.138

8.  Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal.

Authors:  Bing Zhou; Jeffrey S Damrauer; Sean T Bailey; Tanja Hadzic; Youngtae Jeong; Kelly Clark; Cheng Fan; Laura Murphy; Cleo Y Lee; Melissa A Troester; C Ryan Miller; Jian Jin; David Darr; Charles M Perou; Ross L Levine; Maximilian Diehn; William Y Kim
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

Review 9.  The role of hypoxia-inducible factors in metabolic diseases.

Authors:  Frank J Gonzalez; Cen Xie; Changtao Jiang
Journal:  Nat Rev Endocrinol       Date:  2018-12       Impact factor: 43.330

10.  Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT.

Authors:  E Zelzer; Y Levy; C Kahana; B Z Shilo; M Rubinstein; B Cohen
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.